PCSK9 inhibitor added to high-intensity statin therapy to prevent cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention: a randomized, double- blind, placebo-controlled, multicenter SHAWN study

Update your browser to view ScienceDirect.

Request details:

Request ID: 8c211c5e0d6c1726-LAX
IP: 47.97.18.252
UTC time: 2024-09-12T16:00:30+00:00
Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4